AVTX icon

Avalo Therapeutics
AVTX

Overview Fund Trends Analyst Outlook Journalist POV

5 hedge funds and large institutions have $1.58M invested in Avalo Therapeutics in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

less funds holding in top 10

Funds holding in top 10: →

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$24K

Top Sellers

1
-$2.22M
2
-$194K
3
-$71.5K
4
Millennium Management
Millennium Management
New York
-$52.2K
5
Bank of America
Bank of America
North Carolina
-$18K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.31M
2
$200K
3
$29K
4
$24K
5
$11K
6
$3K
7
$2K
8
–
9
–
10
–
11
–
12
–